Start / Exchanges / Vaccine progress and whats next

Vaccine Progress and What’s Next

10 min • 12 november 2020

Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Senaste avsnitt

Are Investors Complacent?

22 juli | 34 min

AI Exchanges: Where Will the Power Come From?

16 juli | 22 min

The Surprising Implications of an Aging Population

8 juli | 16 min

Commodities Outlook: What’s Driving Oil, Gold, and Base Metals

1 juli | 19 min

Mid-year outlook: diversify and hedge

23 juni | 24 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00